Article Text

Download PDFPDF
Hepatitis B and C seroprevalence in Novosibirsk, western Siberia
  1. Oleg V Reshetnikov1,
  2. Alexei A Khryanin2,
  3. Tatiana R Teinina3,
  4. Nikolai A Krivenchuk4,
  5. Irina Yu Zimina4
  1. 1Institute of Internal Medicine, Novosibirsk, Russia
  2. 2Novosibirsk State Medical University, Novosibirsk, Russia
  3. 3Medical College, Novosibirsk, Russia
  4. 4ImDi Diagnostics, Novosibirsk, Russia
  1. Alexei A Khryanin, Main Post Office Box No 221, 630099, Novosibirsk, Russia

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor,—Chronic liver disease represents one of the major public health problems in Western countries. Hepatitis B and C viruses are becoming the main causes of cirrhosis and primary liver carcinoma. Hepatitis C virus (HCV) accounts for approximately 20% of cases of acute hepatitis, 70% of chronic hepatitis, and 30% of end stage liver disease in the United States.1 Today, injecting drug use and high risk sexual activity are the most frequently identified risk factors associated with HCV infection.2 Likewise, in areas of high endemicity of hepatitis B virus (HBV), perinatal transmission is the main route of transmission, whereas in areas of low endemicity, sexual contact among high risk adults …

View Full Text